Remission maintenance in acute lymphocytic leukemia with hydroxyurea.
R. Storrs, Irving J. Wolman, Bernard D. Gussoff, Juliet Hananian
Abstract
R. Storrs, Irving J. Wolman, Bernard D. Gussoff, Juliet Hananian
Abstract
Summary After complete remission had been induced by prednisone and vincristine in children with acute leukemia, hydroxyurea was used in an effort to maintain remission. No significant prolongation of remission occurred despite the appearance of toxicity in over 50% of the high dosage group. An equally significant observation was that the duration of remission produced by prednisone and vincristine was longer in those who had not received vincristine during a prior induced remission.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Summary After complete remission had been induced by prednisone and vincristine in children with acute leukemia, hydroxyurea was used in an effort to maintain remission. No significant prolongation of remission occurred despite the appearance of toxicity in over 50% of the high dosage group. An equally significant observation was that the duration of remission produced by prednisone and vincristine was longer in those who had not received vincristine during a prior induced remission.
Key concepts: Vincristine, Prednisone, Complete remission, Medicine, Leukemia, Spontaneous remission, Acute lymphocytic leukemia, Internal medicine